You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
The FDA said it observed a number of violations of federal law related to the company's Vacutainer blood collection tubes during an inspection.
The investment bank noted that Hologic could be the "biggest beneficiary from tax reform" in its coverage with a potential 8 percent benefit to earnings per share.
The Federal Trade Commission said today that Becton Dickinson and CR Bard have agreed to divest two medical device product lines to settle its complaint that the proposed $24-billion acquisition would negatively impact competition.
The results reflected the divesture of the firm's respiratory solutions business. The firm beat the consensus Wall Street estimates on the top and bottom lines.
Becton Dickinson and Euroclone aim to develop and commercialize the molecular assays for launch outside the US in 2018, and in the US at a later date.
The group is proposing women ages 30 to 65 be screened with cervical cytology every three years or receive testing for high-risk HPV every five years.